InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by Alam Kamran, Chief Financial Officer. Director active across 2 companies, notably Taysha Gene Therapies, Inc.. Aggregated, 2 filings have been recorded. Total volume traded: €332k. The latest transaction was filed on 18 August 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€165,93511,193 shares@ €14.8249100.0% of flow
Common Stock
SEC:0001209191-21-052824·
€165,93511,193 shares@ €14.82490.0097% mcap50.0% of flow
Common Stock
SEC:0001209191-21-052824:0·
2 of 2 declarations
About Alam Kamran
Kamran Alam is the Chief Financial Officer at Taysha Gene Therapies, Inc. He is responsible for the company's financial management, including financial planning and regulatory compliance. Kamran plays a key role in developing financial strategies that support the company's growth. His expertise in finance is essential for ensuring Taysha's financial health.
